413. Healthcare Engagement after Hospitalization Discharge in Patients with HIV/AIDS Infection in a Public Referral Hospital
Session: Poster Abstract Session: HIV Engagement in Care and the Care Cascade
Thursday, October 8, 2015
Room: Poster Hall
Posters
  • 413_IDWPOSTER_MEMC 02-10-15.pdf (514.8 kB)
  • Background: Within the framework of HIV care and treatment continuum, hospital admissions are frequently overlooked. We describe the post-hospitalization discharge outcomes in HIV-infected individuals in terms of outpatient visits at the infectious disease (ID) clinic and virological suppression (VS).

    Methods: Retrospective study based on routine records of hospital admissions and ID outpatient visits of HIV-infected adults attended at a public referral hospital between January 2006 and December 2014. The first admission registered during such period was the index hospitalization; early outpatient follow-up was considered within 30 days of hospital discharge and in the absence of early readmission; VS was less than 400copies/mL at 6 months after hospital discharge.

    Results: We identified 2984 admissions in 2019 HIV/AIDS cases: 65% (n=1302) were male, with 34 years as median age. Upon admission, 83% (n=1365) had prior HIV diagnosis, and 58% (n=473) had a CD4 count < 200cell/mm3. HAART was started in 33% (n=545) prior index hospitalization, in 13% (n=221) during, in 33% (n=542) after, and in 21% (n=337) it was never initiated. Inpatient mortality in the index hospitalizations was 16% (n=333). Within 30 days of hospital discharge, 52% (n=803) had an infectious diseases outpatient follow-up, 43% (n=652) had antiretroviral treatment dispensed and 9% (n=152) were readmitted. VS was found in 43% (n=345) of those who had an outpatient visit within 30 days of hospital discharge, in 30% (n=103) of those with a later visit and in 18% (n=20) of those with no visit (Figure 1).

    Conclusion: High inpatient mortality coupled with low frequencies of outpatient visits within 30 days of hospital discharge and 6 months VS indicate the necessity of strengthening the ambulatory hospitalization care interfaces in HIV/AIDS individuals.

    Miguel Montenegro, MD1,2, Eduardo Gotuzzo, MD, FIDSA1, Elsa Gonzalez, MD1 and Daniel Hoces, MD1, (1)Instituto De Medicina Tropical Alexander Von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru, (2)Facultad De Medicina Alberto Hurtado, Universidad Peruana Cayetano Heredia, Lima, Peru

    Disclosures:

    M. Montenegro, None

    E. Gotuzzo, None

    E. Gonzalez, None

    D. Hoces, None

    << Previous Abstract | Next Abstract

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.